Oral Formulation of Insulin for Preterm Infants
Clinical trial NCT01093638 · TERMINATED
Trial details
- NCT number
- NCT01093638
- Sponsor
- Elgan Pharma Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2013-08-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.